Background Position emission tomography (PET) imaging and cerebrospinal fluid (CSF) analysis are the gold standards for evaluating brain amyloidosis in vivo, but their utility is limited by invasive procedures, high costs of PET, accessibility to PET facilities. Prior research has used machine learning assess based on non-invasive easily accessible information such as cognitive test scores gene...